ANGLE plc Unveils Innovative PD-L1 Assay for Lung Cancer at AACR Conference

ANGLE plc (OTCQX: ANPCY), a leader in liquid biopsy technology, has made significant strides in cancer diagnostics with the introduction of its PD-L1 assay, showcased...